Counterpart Health, Inc., a subsidiary of Clover Health, announced the appointment of David Tsay M.D., Ph.D as Chief Medical Officer on October 8, 2024. Dr. Tsay will play a key role in advancing Counterpart’s clinical strategy and product roadmap for Counterpart Assistant, its proprietary AI-powered physician enablement software platform.
Dr. Tsay is a distinguished physician executive with over two decades of experience in health technology, product development, and clinical innovation. His prior roles include Chief Medical Officer at Cue Health and leading the clinical team for digital health medical device products at Apple.
This appointment is expected to be instrumental as Counterpart Health accelerates its expansion into more value-based healthcare networks and systems nationwide. Dr. Tsay's leadership will help empower providers to deliver high-quality, cost-effective care through the Counterpart Assistant platform.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.